Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
approved crawled date : 2021 - 10 - 12 save search
CytoSorbents Receives Full FDA Investigational Device Exemption (IDE) Approval to Begin U.S. STAR-D Trial on Apixaban and Rivaroxaban Removal by the DrugSorb-ATR™ Antithrombotic Removal System During Urgent Cardiothoracic Surgery
Published: 2021-10-12 (Crawled : 23:00) - cytosorbents.com
CTSO | $0.883 9.01% 8.27% 110K
|
Health Technology
|
| O: -1.3%
H: 0.0%
C: -10.38%
fda drug device iot cardio trial approval
Hoth Therapeutics Receives Approval to Commence Cohort 2 in Clinical Trial of BioLexa for the Treatment of Atopic Dermatitis Patients
Published: 2021-10-12 (Crawled : 14:00) - ir.hoththerapeutics.com
HOTH | $1.15 1.2% 29K
|
Health Technology
|
| O: 0.0%
H: 12.17%
C: 0.87%
treatment dermatitis trial approval atopic dermatitis xin
Arcturus Therapeutics Announces Approval from Vietnam Ministry of Health to Proceed into Phase 3b Study for ARCT-154, a Next Generation STARR™ mRNA Vaccine Targeting SARS-CoV-2 Delta Variant and Other Variants of Concern
Published: 2021-10-12 (Crawled : 13:00) - biospace.com/
TAK | News | $13.38 0.15% 0.9% 1.7M
|
Health Technology
|
| O: 0.21%
H: 0.14%
C: -1.05%
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: -0.16%
H: 0.11%
C: -1.44%
ARCT 4 | $27.93 3.22% 3.11% 310K
|
Health Technology
|
| O: 4.89%
H: 1.6%
C: -1.84%
vaccine phase 3 approval sars-cov-2
VIAVI Xgig Platform Receives PCI-SIG Approval
Published: 2021-10-12 (Crawled : 12:00) - prnewswire.com
VIAV | $8.0 0.63% 0.62% 1.4M
|
Electronic Technology
|
| O: 0.39%
H: 0.0%
C: -1.76%
approval platform
Market Research Finds 99% Of US Clinical Cardiologists Surveyed Report a High Unmet Need for New Innovative Drug Treatments for Early Cardiogenic Shock Patients (ECS) as Windtree Therapeutics Prepares for Clinical Results
Published: 2021-10-12 (Crawled : 12:15) - biospace.com/
WINT | $5.52 1.28% 1.27% 81K
|
Health Technology
|
| O: 1.3%
H: 1.28%
C: -2.56%
treatment eye cardiologists results drug research cardio
LUCIRA™ HEALTH COVID-19 Test Approved for Sale in Singapore
Published: 2021-10-12 (Crawled : 12:00) - globenewswire.com
LHDX | $0.4523 -10.46% 0
|
|
| O: -0.34%
H: 3.94%
C: -0.86%
covid test approval sales covid-19 health
Deciphera Announces Approval of QINLOCK® in Switzerland for the Treatment of Fourth-Line Gastrointestinal Stromal Tumor
Published: 2021-10-12 (Crawled : 12:00) - biospace.com/
DCPH | $14.67 0.62% 0.61% 430K
|
Health Technology
|
| O: 0.19%
H: 7.51%
C: 6.61%
treatment test gastrointestinal switzerland approval
High Tide Receives Approval for Canna Cabana Inc. to Operate in British Columbia
Published: 2021-10-12 (Crawled : 10:00) - hightideinc.com
HITI | $2.135 -0.7% -0.7% 530K
|
Manufacturing
|
| O: 1.4%
H: 2.25%
C: -0.35%
ARVL | News | $0.49 0.37% 2.5M
|
Manufacturing
|
| O: 2.32%
H: 2.91%
C: 0.71%
ACB | $7.44 18.47% 15.59% 9.3M
|
Process Industries
|
| O: 1.14%
H: 1.13%
C: -0.99%
TLRY | $1.84 6.98% 6.52% 25M
|
Process Industries
|
| O: 0.0%
H: 3.94%
C: 1.18%
approval
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News M | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.